Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Oct 18, 2016 (10 years ago)

Zeasorb AF

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Labeling Not Elsewhere Classified: front labels have the incorrect NDC or 0145-1506-01 instead of the correct NDC of 0145-1506-05 and some back labels have the incorrect indication stating "use for the cure of most jock itch" rather than "use for the cure of most athlete's foot".

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

Zeasorb AF (miconazole nitrate), 2%, cures most athlete's foot, Net wt. 2.5 OZ (71 g), Manufactured for: Steifel Laboratories, Inc., Research Triangle Park, NC 27709, UPC 0 73462 15065 1; NDC 0145-1506-01

Affected NDC 0145-1506-01

Compare with the code on your package — it is the most precise check available.

Drug: Miconazole

Recalling firm
GSK Consumer Healthcare
NDC code
0145-1506-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0142-2017 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Miconazole recalls

See all
Class II · Moderate risk

DermaFungal

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

Ongoing cGMP deviation DermaRite Industries, LLC NDC 61924-234-05 D-0162-2026
Class II · Moderate risk

Medline Remedy Clinical TREAT Antifungal Cream

Labeling: Not Elsewhere Classified; Product labeling contains the claim of 'Paraben Free' while the product does in fact contain parabens as part of the formulation/ ingredient list.

Ongoing Labeling / mix-up MEDLINE INDUSTRIES, LP - Northfield D-0315-2024
Class II · Moderate risk

Clinical TREAT Antifungal Powder

CGMP deviations: the product was shipped from the Manufacturer to a Medline warehouse and released to stock while it was still under investigation for low assay results on the active ingredient miconazole nitrate.

Terminated Wrong potency / content MEDLINE INDUSTRIES, LP - Northfield D-0091-2024

Other recalls by GSK Consumer Healthcare

All 2016 recalls